Niki BioSolutions, Inc. (NIKI) vs VivoSim Labs, Inc. (VIVS)

A side-by-side comparison of Niki BioSolutions, Inc. and VivoSim Labs, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NIKI

Niki BioSolutions, Inc.

$403887

$4.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

VIVS

VivoSim Labs, Inc.

$518606

$0.20HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NIKI vs VIVS

growth of $100 · dividends reinvested · last 1y

NIKI -94.8% (-94.8%/yr)VIVS -88.0% (-88.0%/yr)VIVS compounded faster over this window

NIKI VIVS

NIKI vs VIVS: by the numbers

•VIVS is the larger company ($518606 vs $403887 market cap).
•Both run net losses; NIKI's is the smaller (0.00% vs -11016.07% net margin).

Metrics side by side

Valuation

Metric	NIKI	VIVS
P/S ratio	N/A	4.63
P/B ratio	0.02	N/A

Profitability

Metric	NIKI	VIVS
Gross margin	0.00%	100.00%
Operating margin	0.00%	-8567.94%
Net margin	0.00%	-11016.07%
ROE	-5.89%	N/A
ROIC	-10.38%	-579.89%

Growth (annualized)

Metric	NIKI	VIVS
Total return CAGR (5Y)	-71.40%	N/A

Go deeper

Full NIKI analysis Full VIVS analysis Interactive comparison tool

Dig into the metrics

Niki BioSolutions ROE VivoSim Labs ROE Niki BioSolutions operating margin VivoSim Labs operating margin Niki BioSolutions revenue growth VivoSim Labs revenue growth Niki BioSolutions free cash flow VivoSim Labs free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.